Agios

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agios and other ETFs, options, and stocks.

About AGIO

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology.

CEO

Brian M. Goff

CEOBrian M. Goff

Employees

540

Employees540

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2007

Founded2007

Employees

540

Employees540

AGIO Key Statistics

Market cap

2.45B

Market cap2.45B

Price-Earnings ratio

-5.90

Price-Earnings ratio-5.90

Dividend yield

—

Dividend yield—

Average volume

1.37M

Average volume1.37M

High today

$42.93

High today$42.93

Low today

$40.26

Low today$40.26

Open price

$42.93

Open price$42.93

Volume

1.10M

Volume1.10M

52 Week high

$46.00

52 Week high$46.00

52 Week low

$22.24

52 Week low$22.24

Stock Snapshot

Agios(AGIO) stock is priced at $41.23, giving the company a market capitalization of 2.45B. It carries a P/E multiple of -5.90.

On 2026-07-10, Agios(AGIO) stock moved within a range of $40.26 to $42.93. With shares now at $41.23, the stock is trading +2.4% above its intraday low and -4.0% below the session's peak.

Trading volume for Agios(AGIO) stock has reached 1.1M, versus its average volume of 1.37M.

Over the past 52 weeks, Agios(AGIO) stock has traded between a high of $46.00 and a low of $22.24.

AGIO News

The Motley Fool 13h

Here's Why Shares in Novo Nordisk Rival, Agios Pharmaceutical, Soared This Week

Agios Pharmaceuticals (AGIO +0.07%) stock rose by 13.8% during the week through Friday morning. It's a move driven by the Food and Drug Administration's (FDA) a...

Nasdaq 3d

Agios Pharmaceuticals Reaches Analyst Target Price

In recent trading, shares of Agios Pharmaceuticals Inc (Symbol: AGIO) have crossed above the average analyst 12-month target price of $53.38, changing hands for...

The Motley Fool 3d

Here's Why Agios Pharmaceuticals Stock Soared Today (Hint: It's FDA-Related) - The Motley Fool

...

Analyst ratings

70%

of 10 ratings

Buy

70%

Hold

30%

Sell

More AGIO News

TipRanks 3d

Agios Pharmaceuticals rises 13.5%

Agios Pharmaceuticals (AGIO) is up 13.5%, or $5.04 to $42.43. Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident...

Simply Wall St 5d

Agios Pharmaceuticals Could Be 8% Below Fair Value On Growth Index Shift

Advertisement Index reshuffle puts Agios Pharmaceuticals in the growth spotlight Agios Pharmaceuticals (AGIO) has shifted index buckets, dropping from the Rus...

People also own

Based on the portfolios of people who own AGIO. This list is generated using Robinhood data, and it’s not a recommendation.

Palantir Technologies

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.